Annotations: 2LXW

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	EUF08690	e2lxwA1	A: few secondary structure elements	X: beta-beta-alpha zinc fingers	H: beta-beta-alpha zinc fingers (From Topology)	T: beta-beta-alpha zinc fingers	F: EUF08690	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	6.10.250.1730	Special	Helix non-globular	Single alpha-helices involved in coiled-coils or other helix-helix interfaces		CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF18608	XIAP-associated factor 1 C-terminal domain (XAF1_C)	XIAP-associated factor 1 C-terminal domain	XIAP-associated factor 1 (XAF1) is a 301-amino acids interferon (INF)-inducible pro-apoptotic protein. The XIAP binding region within XAF1, XIAP RING binding site, is located at the C-terminal portion of XAF1. This entry represents the C-terminal reg ...	XIAP-associated factor 1 (XAF1) is a 301-amino acids interferon (INF)-inducible pro-apoptotic protein. The XIAP binding region within XAF1, XIAP RING binding site, is located at the C-terminal portion of XAF1. This entry represents the C-terminal region which is functionally identified as XIAP RING-binding domain of XAF1 [1].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	XIAP-associated factor 1	molecular sequestering activity cation binding transition metal ion binding zinc ion binding ion binding binding metal ion binding small molecule binding	multicellular organismal process regulation of cellular process cellular biosynthetic process negative regulation of biological process negative regulation of cellular metabolic process negative regulation of type I interferon production organic substance metabolic process cytokine production organic substance biosynthetic process negative regulation of cellular process regulation of cytokine production regulation of multicellular organismal process negative regulation of macromolecule metabolic process regulation of biosynthetic process multicellular organismal process regulation of cellular process cellular biosynthetic process negative regulation of biological process negative regulation of cellular metabolic process negative regulation of type I interferon production organic substance metabolic process cytokine production organic substance biosynthetic process negative regulation of cellular process regulation of cytokine production regulation of multicellular organismal process negative regulation of macromolecule metabolic process regulation of biosynthetic process regulation of biological process type I interferon production cellular metabolic process negative regulation of metabolic process biological regulation negative regulation of cytokine production regulation of cellular metabolic process regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process negative regulation of cellular biosynthetic process regulation of cellular biosynthetic process regulation of gene expression negative regulation of gene expression biosynthetic process negative regulation of biosynthetic process negative regulation of macromolecule biosynthetic process metabolic process cellular process regulation of macromolecule biosynthetic process macromolecule metabolic process negative regulation of multicellular organismal process regulation of metabolic process regulation of type I interferon production apoptotic process cell death programmed cell death response to interferon-beta response to organic substance response to stimulus response to chemical response to cytokine	membrane-bounded organelle intracellular organelle intracellular anatomical structure mitochondrion organelle cytoplasm cellular anatomical entity intracellular membrane-bounded organelle cytosol nucleus membrane-enclosed lumen intracellular organelle lumen nucleoplasm organelle lumen membrane-bounded organelle intracellular organelle intracellular anatomical structure mitochondrion organelle cytoplasm cellular anatomical entity intracellular membrane-bounded organelle cytosol nucleus membrane-enclosed lumen intracellular organelle lumen nucleoplasm organelle lumen nuclear lumen

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR049439	TRAFD1/XAF1, zinc finger	Domain
A	IPR013083	Zinc finger, RING/FYVE/PHD-type	Homologous Superfamily
A	IPR001293	Zinc finger, TRAF-type	Domain
A	IPR031220	XIAP-associated factor 1, C-terminal superfamily	Homologous Superfamily
A	IPR041386	XIAP-associated factor 1, C-terminal	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q6GPH4	malignant colon neoplasm mixed glioma malignant glioma colorectal cancer influenza juvenile dermatomyositis lung carcinoma malignant mesothelioma medulloblastoma nasopharyngeal carcinoma atopic eczema ovarian cancer cancer pituitary cancer colorectal carcinoma malignant colon neoplasm mixed glioma malignant glioma colorectal cancer influenza juvenile dermatomyositis lung carcinoma malignant mesothelioma medulloblastoma nasopharyngeal carcinoma atopic eczema ovarian cancer cancer pituitary cancer colorectal carcinoma Sjogren syndrome cutaneous lupus erythematosus tuberculosis gastric cancer hepatocellular carcinoma interstitial cystitis large cell medulloblastoma Malignant neoplasm of stomach non-small cell lung carcinoma benign colon neoplasm pancreatic ductal adenocarcinoma colonic neoplasm psoriasis subependymal giant cell astrocytoma cystic fibrosis ulcerative colitis gastric neoplasm hereditary diffuse gastric adenocarcinoma invasive ductal breast carcinoma lung cancer malignant pancreatic neoplasm multiple sclerosis osteosarcoma breast cancer pancreatic intraductal papillary-mucinous neoplasm sarcoidosis Crohn disease systemic lupus erythematosus dermatomyositis glioma

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.